Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis

Histopathology

Volumn 39, Issue 1, 2001, Pages 66-73

  Libbrecht, L ^a   Craninx, M ^a   Nevens, F ^a   Desmet, V ^a   Roskams, T ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Chronic viral hepatitis; Dysplasia; Hepatocellular carcinoma; Liver biopsy; Risk factor

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DYSPLASIA; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HEPATITIS VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL; LIVER CELL CARCINOMA; LIVER CELL DYSPLASIA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; BIOPSY; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; CONTRACEPTIVES, ORAL; FEMALE; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SMOKING;

DNA VIRUSES; HEPATITIS C VIRUS;

EID: 0034856920     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2001.01172.x     Document Type: Article

References (46)

1. Epidemiology of primary liver cancer
2. Hepatocellular carcinoma
3. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience
4. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16-year population-based study
5. Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis
6. A cost-benefit analysis of the benefit of screening for hepatocellular carcinoma in hepatitis B carriers
7. Liver cell dysplasia: A premalignant condition
8. Morphologic studies of the liver cell dysplasia
9. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: A prospective study
10. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis
11. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
12. Classification of chronic hepatitis: A need for reassessment
13. Hepatic oncocytes. Incidence, staining characteristics, and ultrastructural features
14. Hepatic neoformations
15. The measurement of observer agreement for categorical data
16. Conditional inference for subject-specific and marginal agreement: Two families of agreement measures
17. Non-parametric estimation from incomplete observations
18. Asymptomatically efficient rank invariant procedures
19. Regression models and life-tables
20. Hepatitis-B surface antigen in tumour tissue and non-tumorous liver in black patients with hepatocellular carcinoma
21. Liver cell dysplasia and hepatocellular carcinoma: A histological and immunohistochemical study
22. Human hepatic preneoplasia: Phenotypes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia
23. Preneoplastic cellular changes in liver
24. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection
25. Hepatitis C virus related cirrhosis: Time to occurrence of hepatocellular carcinoma and death
26. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: Matched case-control study, pathological analysis, and pathogenetic hypothesis
27. Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B
28. Liver cell dysplasia in association with hepatocellular carcinoma, cirrhosis and hepatitis B surface antigen in Hong Kong
29. Liver cell dysplasia and hepatitis B surface antigen in liver cirrhosis and hepatocellular carcinoma
30. Liver cell dysplasia accompanying hepatocellular carcinoma in southern Africa. Differences between urban and rural populations
31. Incidence and diagnostic features of macroregenerative nodules vs. small hepatocellular carcinoma in cirrhotic livers
32. Unusual hepatocellular lesions in primary biliary cirrhosis resembling but unrelated to hepatocellular neoplasms
33. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants
34. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma
35. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis
36. Reactive oxygen species and nitric oxide in viral diseases
37. Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia
38. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma
39. Premalignant lesions and hepatocellular carcinoma in a non-cirrhotic alcoholic patient with iron overload and normal transferrin saturation
40. Morphological precursors of hepatocellular carcinoma: A morphometrical analysis
41. Liver cell dysplasia: Reactivities for c-met protein, Rb protein, E-cadherin and transforming growth factor-beta 1 in comparison with hepatocellular carcinoma
42. The immunohistochemical phenotype of dysplastic foci in human liver: Correlation with putative progenitor cells
43. Pathogenesis of hepatocellular carcinoma: Sequential cellular, molecular, and metabolic changes
44. Altered hepatic foci: Their role in murine hepatocarcinogenesis
45. Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis